WKN: | A0N99U |
ISIN: | CNE100000FN7 |
Land: | China |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Pharma |
Weshalb die Sinopharm Group Co-Aktie
ein D-Rating hat,
erfahren Sie im Performance-Check
vom 04. August 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2014 | 2,06 | 2,84 | 37,86% |
2 | 2012 | 1,83 | 2,33 | 27,32% |
3 | 2015 | 2,84 | 3,60 | 26,76% |
4 | 2022 | 1,90 | 2,35 | 23,68% |
5 | 2024 | 2,35 | 2,65 | 12,77% |
6 | 2016 | 3,60 | 3,96 | 10,00% |
7 | 2010 | 2,46 | 2,67 | 8,54% |
8 | 2023 | 2,35 | 2,35 | 0,00% |
9 | 2018 | 3,56 | 3,55 | -0,28% |
10 | 2021 | 2,06 | 1,90 | -7,77% |
11 | 2019 | 3,55 | 3,22 | -9,30% |
12 | 2017 | 3,96 | 3,56 | -10,10% |
13 | 2013 | 2,33 | 2,06 | -11,59% |
14 | 2025 | 2,65 | 2,09 | -21,13% |
15 | 2011 | 2,67 | 1,83 | -31,46% |
16 | 2020 | 3,22 | 2,06 | -36,02% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2020 | 3,22 | 2,06 | -36,02% |
2 | 2011 | 2,67 | 1,83 | -31,46% |
3 | 2025 | 2,65 | 2,09 | -21,13% |
4 | 2013 | 2,33 | 2,06 | -11,59% |
5 | 2017 | 3,96 | 3,56 | -10,10% |
6 | 2019 | 3,55 | 3,22 | -9,30% |
7 | 2021 | 2,06 | 1,90 | -7,77% |
8 | 2018 | 3,56 | 3,55 | -0,28% |
9 | 2023 | 2,35 | 2,35 | 0,00% |
10 | 2010 | 2,46 | 2,67 | 8,54% |
11 | 2016 | 3,60 | 3,96 | 10,00% |
12 | 2024 | 2,35 | 2,65 | 12,77% |
13 | 2022 | 1,90 | 2,35 | 23,68% |
14 | 2015 | 2,84 | 3,60 | 26,76% |
15 | 2012 | 1,83 | 2,33 | 27,32% |
16 | 2014 | 2,06 | 2,84 | 37,86% |